Tenders

Reactivation of Siemensbahn Including Related Measures to Westhafen

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Tocilizumab (Excl. Infusion Solution Concentrate), Atc L04ac07 (Obo) for the Period October 1St, 2024 - November 30Th, 2025

Clinical Decision and Support System // Clinical Decision Support Software (Cdss)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V on Active Ingredients (Medicines) - Vv_79

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Baclofen (Excluding Oral Dosage Form), Atc M03bx01 (Obg) for the Period October 1St, 2024 - September 30Th, 2026

Operating Locations (Bso) in the General Contractor Model for Korra (Rhine-Alpine Corridor)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Bosutinib, Atc L01ea04 (Obg) for the Period October 1St, 2024 - September 30Th, 2026

Security and Surveillance Services

Delivery, Installation and Maintenance of a Photon Counting Ct as Well as Planning and Conversion of the Usable Areas

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Abiraterone (Except Potency 500 Mg), Atc L02bx03 (Obg) for the Period October 1St, 2024 - September 30Th, 2026